Candida auris is a species of ascomycetous fungus belonging to the Candida genus, and was first described clinically after it was isolated in Japan in 2009. Since then, C. auris clinical isolates have become increasingly common as contributors to nosocomial
bloodstream infections (BSI) in numerous countries globally, and more concerningly are increasingly multidrug-resistant. Patients with debilitated immune systems that spend long periods of time in hospitals and other healthcare centres are especially
susceptible to C. auris infections.
Key Features:
- No cold chain shipping
- The kit is designed to have a broad detection profile
- Under optimal PCR conditions genesig C. auris detection kits have very high priming efficiencies of >95% and can detect less than 100 copies of target template
- Available for use on any qPCR instrument format (open platform)
- Results available within 90 minutes
- Primers represent 100% homology with >95% of the NCBI database reference sequences available at the time of design
- A C. auris specific primer and FAM hydrolysis probe mix
Detection Profile: The genesig™ Advanced Kit for C. auris is configured for use with any real-time PCR instrument equipped to detect amplification in the FAM channel.